|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Octapharma acquisition of a plasma fractionation plant in Springe, Germany from German Red Cross organizations
May 8, 2008
The Norwegian Self-Sufficiency Project Celebrates
20-Year Anniversary!
April 7, 2008
Annual Accounts 2007
March 26, 2008
Welcome to Octapharma!
Octapharma, a Swiss-based company, is an independent, global plasma fractionation specialist. Its core business is the development, production and sale of high quality plasma derivatives.
The information provided on the Octapharma website is based on world-wide business and approved international product specifications. As registration status and prescribing information for our products vary from country to country, you are encouraged to contact your local Octapharma office for country specific information. In addition, Octapharma is developing specific country web pages which may also be referenced. US residents, for example, should refer to Octapharma USA on the pull down list below for FDA approved product information:
Last update 5/8/2008, © Octapharma AG |
|
 |
|
|
|
